151 related articles for article (PubMed ID: 15258796)
1. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis.
Oka Y; Kanbayashi T; Mezaki T; Iseki K; Matsubayashi J; Murakami G; Matsui M; Shimizu T; Shibasaki H
J Neurol; 2004 Jul; 251(7):885-6. PubMed ID: 15258796
[No Abstract] [Full Text] [Related]
2. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions.
Kato T; Kanbayashi T; Yamamoto K; Nakano T; Shimizu T; Hashimoto T; Ikeda S
Intern Med; 2003 Aug; 42(8):743-5. PubMed ID: 12924505
[TBL] [Abstract][Full Text] [Related]
3. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887
[TBL] [Abstract][Full Text] [Related]
4. A hypersomnolent girl with decreased CSF hypocretin level after removal of a hypothalamic tumor.
Arii J; Kanbayashi T; Tanabe Y; Ono J; Nishino S; Kohno Y
Neurology; 2001 Jun; 56(12):1775-6. PubMed ID: 11425955
[No Abstract] [Full Text] [Related]
5. Undetectable CSF hypocretin-1 in "Hashimoto's encephalopathy" associated with coma.
Castillo PR; Mignot E; Woodruff BK; Boeve BF
Neurology; 2004 May; 62(10):1909. PubMed ID: 15159515
[No Abstract] [Full Text] [Related]
6. Low levels of ventricular CSF orexin/hypocretin in advanced PD.
Drouot X; Moutereau S; Nguyen JP; Lefaucheur JP; Créange A; Remy P; Goldenberg F; d'Ortho MP
Neurology; 2003 Aug; 61(4):540-3. PubMed ID: 12939433
[TBL] [Abstract][Full Text] [Related]
7. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284
[TBL] [Abstract][Full Text] [Related]
8. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness.
Constantinescu CS; Niepel G; Patterson M; Judd A; Braitch M; Fahey AJ; Harikrishnan S; Edwards LJ; Tench CR; Bennett GW; Ghatei M
J Neurol Sci; 2011 Aug; 307(1-2):127-31. PubMed ID: 21605873
[TBL] [Abstract][Full Text] [Related]
9. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions.
Nozaki H; Shimohata T; Kanbayashi T; Sagawa Y; Katada S; Satoh M; Onodera O; Tanaka K; Nishizawa M
Sleep Med; 2009 Feb; 10(2):253-5. PubMed ID: 18226957
[TBL] [Abstract][Full Text] [Related]
10. The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders.
Kunimoto M
Intern Med; 2003 Aug; 42(8):634-5. PubMed ID: 12924483
[No Abstract] [Full Text] [Related]
11. Hypersomnia and low cerebrospinal fluid hypocretin levels in acute disseminated encephalomyelitis.
Yoshikawa S; Suzuki S; Kanbayashi T; Nishino S; Tamai H
Pediatr Neurol; 2004 Nov; 31(5):367-70. PubMed ID: 15519122
[TBL] [Abstract][Full Text] [Related]
12. A case of acute disseminated encephalomyelitis presenting hypersomnia with decreased hypocretin level in cerebrospinal fluid.
Kubota H; Kanbayashi T; Tanabe Y; Takanashi J; Kohno Y
J Child Neurol; 2002 Jul; 17(7):537-9. PubMed ID: 12269735
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
14. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta Y; Santamaria J; Ratti L; Tolosa E; Iranzo A; Muñoz E; Valldeoriola F; Casamitjana R; Ríos J; Marti MJ
Brain; 2009 Dec; 132(Pt 12):3308-17. PubMed ID: 19858078
[TBL] [Abstract][Full Text] [Related]
16. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.
Martínez-Rodríguez JE; Lin L; Iranzo A; Genis D; Martí MJ; Santamaria J; Mignot E
Sleep; 2003 May; 26(3):287-90. PubMed ID: 12749547
[TBL] [Abstract][Full Text] [Related]
17. [Excessive daytime sleepiness and low CSF orexin-A/hypocretin-I levels in a patient with probable progressive supranuclear palsy].
Hattori Y; Hattori T; Mukai E; Mori H; Mizuno Y; Kayukawa Y; Okada T; Kanbayashi T
No To Shinkei; 2003 Dec; 55(12):1053-6. PubMed ID: 14870576
[TBL] [Abstract][Full Text] [Related]
18. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
[TBL] [Abstract][Full Text] [Related]
19. Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis.
Knudsen S; Jennum PJ; Korsholm K; Sheikh SP; Gammeltoft S; Frederiksen JL
Mult Scler; 2008 Jul; 14(6):734-8. PubMed ID: 18505777
[TBL] [Abstract][Full Text] [Related]
20. CSF hypocretin measures in patients with obstructive sleep apnea.
Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
